Related Experiment Video
Updated: Jul 20, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Expert Opinion on Optimizing Suboptimal Basal Insulin Titration in India: Addressing Challenges and Leveraging
Sanjay Kalra1, Pramila Kalra2, Kalyan Kumar Gangopadhyay3
1Bharti Hospital, Karnal, Haryana, India.
Summary
Optimizing basal insulin titration for type 2 diabetes mellitus (T2DM) remains challenging. Digital health solutions show promise for improving self-management, patient engagement, and glycemic control.
Area of Science:
- Endocrinology
- Digital Health
- Diabetes Management
Background:
- Basal insulin titration is essential for type 2 diabetes mellitus (T2DM) glycemic control.
- Suboptimal insulin dosing presents significant challenges for patients and healthcare providers.
- Current methods for insulin titration often fall short of individualized targets.
Purpose of the Study:
- To discuss limitations in current basal insulin titration for T2DM.
- To explore the potential of digital health solutions in addressing these limitations.
- To identify how technology can enhance diabetes self-management and patient outcomes.
Main Methods:
- An expert panel of endocrinologists and diabetologists convened in October 2024.
- The panel discussed challenges in basal insulin titration and the role of digital health.
- Focus was placed on app-based services and real-time data monitoring.
Main Results:
- Digital health tools can facilitate more effective patient self-management.
- These technologies can enhance patient engagement and communication in T2DM care.
- Leveraging real-time data and remote consultations offers a scalable approach.
Conclusions:
- Digital health technologies present a promising avenue to overcome complexities in basal insulin titration.
- These tools can improve glycemic outcomes and overall diabetes management for T2DM patients.
- Tailored treatment approaches enabled by digital health are key to progress.
Related Concept Videos
01:29Issues And Trends In Healthcare Delivery System
5.5K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.5K
01:22Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
01:15Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
01:25Insulin: Biosynthesis, Chemistry, and Preparation
329
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
329
01:27Insulin Formulations: Types and Delivery
147
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
147
01:16Insulin: Dosing Regimen and Adverse Effects
134
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
134